Teva Pharmaceutical Industries Ltd., one of the largest generic drugmakers in the world, has recalled more than 2.5 million vials of drugs that the company said may not be sterile.
The vials — many filled with medicine used to help treat cancer — may have contained mold contamination stemming from water leaks, U.S. inspectors discovered at a Teva production plant in California.
The company has temporarily stopped drug production at the Irvine, Calif., facility and is reviewing the concerns raised by the Food and Drug Administration, according to a Teva email response to Bloomberg.
